Conspirituality cover image

Brief: The Promises & (Mostly) Perils of Ketamine Therapy

Conspirituality

00:00

The Future of Ketamine

In March 2019, the FDA approved the usage of ketamine under the trade name Sbravado for clinical use in treatment resistant depression therapy. Ketamine is not a psychedelic, but rather a hallucinogen and a disassociative. It has been used broadly as a sedative and anesthetic to aid in emergency surgeries in war zones.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app